---
$id: https://graph.org.ai/products/commodity/51181621
$type: Product
source: UNSPSC
code: "51181621"
title: "Thyrotropin-releasing hormone (trh) or thyrotropin-releasing factor (trf) or thyroliberin or protirelin"
class: "51181600"
classTitle: "Thyroid and antithyroid drugs"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Thyrotropin-releasing hormone (trh) or thyrotropin-releasing factor (trf) or thyroliberin or protirelin

**UNSPSC Code**: 51181621
**Class**: [Thyroid and antithyroid drugs](Thyroid and antithyroid drugs.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a hypothalmic hormone with the molecular formula C16H22N6O4, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 5Y5F15120W, chemically known as l-prolinamide, 5-oxo-l-prolyl-l-histidyl- but more generally known as protirelin, which bears U.S. National Institutes of Health Compound Identifier 32281. The European Medicines Agency schedules Protirelin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10142MIG. The term PROTIRELIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 28, No. 10 1974, List 14). The World Health Organization schedules protirelin in its Anatomical Therapeutic Chemical (ATC) Classification. PROTIRELIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: C1CC(N(C1)C(=O)C(CC2=CN=CN2)NC(=O)C3CCC(=O)N3)C(=O)O.

